Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF)

PHASE1CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

January 17, 2023

Primary Completion Date

June 5, 2025

Study Completion Date

June 5, 2025

Conditions
Hepatic EncephalopathyAcute-On-Chronic Liver Failure
Interventions
DRUG

Branch Chain Amino Acid

Intravenous branched chain amino acids will be given for 3 days to patients in experimental arm

DRUG

Lactulose

Oral lactulose will be given to patients in both arms

Trial Locations (1)

160012

Dr. Madhumita Premkumar, Chandigarh

All Listed Sponsors
collaborator

Amrita Institute of Medical Sciences & Research Center

OTHER

collaborator

Asian Institute of Gastroenterology, India

OTHER

collaborator

All India Institute of Medical Sciences, Bhubaneswar

OTHER

collaborator

Kalinga Institute of Medical Sciences, Bhubaneswar

UNKNOWN

lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER